We were unable to assess the impact of surveillance, but 6-monthly liver ultrasounds, with or without serum alpha-fetoprotein testing, have been shown to improve early detection, receipt of curative treatment and survival [7] and is therefore recommended for people with cirrhosis [8]. This evidence concerns the gene AFP and Cirrhosis.